|
FBXW2 |
F-box and WD repeat domain containing 2 |
- Association of TriC/CCT with target proteins during biosynthesis
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
FKBP11 |
FKBP prolyl isomerase 11 |
|
|
|
|
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
- Oxidative Stress Induced Senescence
- Senescence-Associated Secretory Phenotype (SASP)
- FCERI mediated MAPK activation
- Activation of the AP-1 family of transcription factors
- Interleukin-4 and Interleukin-13 signaling
- TP53 Regulates Transcription of DNA Repair Genes
- Estrogen-dependent gene expression
- NGF-stimulated transcription
- NGF-stimulated transcription
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- NPAS4 regulates expression of target genes
- Regulation of PD-L1(CD274) transcription
|
- Pseudoephedrine
- Nandrolone decanoate
- Nadroparin
|
|
|
FUS |
FUS RNA binding protein |
- mRNA Splicing - Major Pathway
- Processing of Capped Intron-Containing Pre-mRNA
|
|
- Myxoid liposarcoma
- Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
|
|
GLIS1 |
GLIS family zinc finger 1 |
|
|
|
|
GOPC |
golgi associated PDZ and coiled-coil motif containing |
- RHO GTPases regulate CFTR trafficking
- RHOQ GTPase cycle
|
|
|
|
GTF2B |
general transcription factor IIB |
- HIV Transcription Initiation
- RNA Polymerase II HIV Promoter Escape
- Transcription of the HIV genome
- RNA Polymerase II Pre-transcription Events
- RNA polymerase II transcribes snRNA genes
- RNA polymerase II transcribes snRNA genes
- RNA Polymerase II Promoter Escape
- RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
- RNA Polymerase II Transcription Initiation
- RNA Polymerase II Transcription Initiation And Promoter Clearance
|
|
|
|
HDAC1 |
histone deacetylase 1 |
- Transcription of E2F targets under negative control by DREAM complex
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- p75NTR negatively regulates cell cycle via SC1
- Formation of the beta-catenin:TCF transactivating complex
- NOTCH1 Intracellular Domain Regulates Transcription
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Deactivation of the beta-catenin transactivating complex
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- NoRC negatively regulates rRNA expression
- SUMOylation of chromatin organization proteins
- Repression of WNT target genes
- Repression of WNT target genes
- Regulation of TP53 Activity through Acetylation
- G1/S-Specific Transcription
- RNA Polymerase I Transcription Initiation
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Estrogen-dependent gene expression
- Loss of MECP2 binding ability to 5mC-DNA
- Regulation of MECP2 expression and activity
- MECP2 regulates neuronal receptors and channels
- MECP2 regulates transcription of neuronal ligands
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- Potential therapeutics for SARS
- STAT3 nuclear events downstream of ALK signaling
- Nuclear events stimulated by ALK signaling in cancer
- Negative Regulation of CDH1 Gene Transcription
- Regulation of MITF-M-dependent genes involved in apoptosis
- Regulation of MITF-M-dependent genes involved in cell cycle and proliferation
- Factors involved in megakaryocyte development and platelet production
- Regulation of endogenous retroelements by KRAB-ZFP proteins
- Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
- Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
- Transcriptional and post-translational regulation of MITF-M expression and activity
|
- Valproic acid
- Arsenic trioxide
- Decitabine
- Zinc
- Vorinostat
- Vorinostat
- Belinostat
- Pracinostat
- Romidepsin
- Romidepsin
- Panobinostat
- Phenylbutyric acid
- Fingolimod
- Mocetinostat
- Entinostat
- Abexinostat
- Abexinostat
- Givinostat
- Pyroxamide
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
HDAC2 |
histone deacetylase 2 |
- p75NTR negatively regulates cell cycle via SC1
- NOTCH1 Intracellular Domain Regulates Transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- NoRC negatively regulates rRNA expression
- SUMOylation of chromatin organization proteins
- Regulation of TP53 Activity through Acetylation
- RNA Polymerase I Transcription Initiation
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Regulation of MECP2 expression and activity
- MECP2 regulates neuronal receptors and channels
- FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
- Potential therapeutics for SARS
- STAT3 nuclear events downstream of ALK signaling
- Negative Regulation of CDH1 Gene Transcription
- Factors involved in megakaryocyte development and platelet production
- Regulation of endogenous retroelements by KRAB-ZFP proteins
- Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
- Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
|
- Pravastatin
- Lovastatin
- Theophylline
- Valproic acid
- Valproic acid
- Simvastatin
- Atorvastatin
- Fluvastatin
- Aminophylline
- Decitabine
- Oxtriphylline
- Vorinostat
- Vorinostat
- Belinostat
- Pracinostat
- Romidepsin
- Romidepsin
- Panobinostat
- Phenylbutyric acid
- Tixocortol
- Mocetinostat
- Entinostat
- Abexinostat
- Givinostat
- Pyroxamide
|
|
|
HDAC3 |
histone deacetylase 3 |
- p75NTR negatively regulates cell cycle via SC1
- PPARA activates gene expression
- PPARA activates gene expression
- NOTCH1 Intracellular Domain Regulates Transcription
- Transcriptional activation of mitochondrial biogenesis
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Association of TriC/CCT with target proteins during biosynthesis
- Regulation of lipid metabolism by PPARalpha
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- RUNX2 regulates osteoblast differentiation
- Regulation of PTEN gene transcription
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
- STAT3 nuclear events downstream of ALK signaling
- Cytoprotection by HMOX1
- Heme signaling
- Heme signaling
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
- Valproic acid
- Decitabine
- Vorinostat
- Vorinostat
- Belinostat
- Pracinostat
- Romidepsin
- Panobinostat
- Phenylbutyric acid
- Mocetinostat
- Entinostat
- Abexinostat
- Givinostat
- Pyroxamide
|
|
|
HEXIM1 |
HEXIM P-TEFb complex subunit 1 |
|
|
|
|
HMGA2 |
high mobility group AT-hook 2 |
- Formation of Senescence-Associated Heterochromatin Foci (SAHF)
|
|
|
|
HMGB1 |
high mobility group box 1 |
- ER-Phagosome pathway
- Apoptosis induced DNA fragmentation
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- TAK1-dependent IKK and NF-kappa-B activation
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- Pyroptosis
- Regulation of TLR by endogenous ligand
- Neutrophil degranulation
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- TRAF6 mediated NF-kB activation
|
- Chloroquine
- Ethyl pyruvate
|
|
|
HSPA4 |
heat shock protein family A (Hsp70) member 4 |
- Regulation of HSF1-mediated heat shock response
|
|
|
|
IGF1R |
insulin like growth factor 1 receptor |
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- IRS-related events triggered by IGF1R
- SHC-related events triggered by IGF1R
- Extra-nuclear estrogen signaling
- Respiratory syncytial virus (RSV) attachment and entry
|
- Insulin human
- Insulin lispro
- Insulin glargine
- Insulin pork
- Mecasermin
- Insulin aspart
- Insulin detemir
- Insulin glulisine
- Phosphoaminophosphonic Acid-Adenylate Ester
- ATL1101
- XL228
- rhIGFBP-3
- Linsitinib
- Teprotumumab
- (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione
- 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
- Nandrolone decanoate
- Somatrem
- Insulin beef
- Insulin degludec
- Insulin argine
- Insulin peglispro
- Insulin tregopil
- Dalotuzumab
- Cixutumumab
- Brigatinib
- Mecasermin rinfabate
- BMS-754807
- KW-2450 free base
|
- Synovial sarcoma
- Malignant pleural mesothelioma
|
|
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
- Activation of NF-kappaB in B cells
- Activation of NF-kappaB in B cells
- ER-Phagosome pathway
- NOD1/2 Signaling Pathway
- TICAM1, RIP1-mediated IKK complex recruitment
- RIP-mediated NFkB activation via ZBP1
- Downstream TCR signaling
- p75NTR recruits signalling complexes
- NF-kB is activated and signals survival
- FCERI mediated NF-kB activation
- TAK1-dependent IKK and NF-kappa-B activation
- Regulation of TNFR1 signaling
- TNFR1-induced NF-kappa-B signaling pathway
- IKBKB deficiency causes SCID
- IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
- IkBA variant leads to EDA-ID
- CLEC7A (Dectin-1) signaling
- MAP3K8 (TPL2)-dependent MAPK1/3 activation
- Interleukin-1 signaling
- TRAF6 mediated NF-kB activation
- NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
- IRAK1 recruits IKK complex
- IKK complex recruitment mediated by RIP1
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
- Regulation of NF-kappa B signaling
- PKR-mediated signaling
- SLC15A4:TASL-dependent IRF5 activation
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
- Modulation of host responses by IFN-stimulated genes
|
- Mesalazine
- Acetylsalicylic acid
- Auranofin
- Arsenic trioxide
- MLN0415
- Acetylcysteine
- Ertiprotafib
- Fostamatinib
|
|
|
IKBKE |
inhibitor of nuclear factor kappa B kinase subunit epsilon |
- SUMOylation of immune response proteins
- TNFR1-induced proapoptotic signaling
- Regulation of TNFR1 signaling
- TICAM1-dependent activation of IRF3/IRF7
- TRAF3-dependent IRF activation pathway
- TRAF6 mediated IRF7 activation
- Negative regulators of DDX58/IFIH1 signaling
- Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
- SARS-CoV-1 activates/modulates innate immune responses
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
- Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
|
|
|
ING4 |
inhibitor of growth family member 4 |
|
|
|
|
IRAK1BP1 |
interleukin 1 receptor associated kinase 1 binding protein 1 |
|
|
|
|
IRF1 |
interferon regulatory factor 1 |
- Pyroptosis
- Interferon gamma signaling
- Interferon alpha/beta signaling
- Factors involved in megakaryocyte development and platelet production
- Regulation of PD-L1(CD274) transcription
|
|
|